ID   LL58
AC   CVCL_8258
DR   HIVReagentProgram; ARP-811
DR   Wikidata; Q54902693
RX   Patent=US5178999;
RX   PubMed=3033285;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9693.
CC   Virology: Chronically infected with HIV-1.
CC   Doubling time: 24-48 hours (HIVReagentProgram=ARP-811).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8277 ! X50-7
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
RX   Patent=US5178999;
RA   Miller G., Dahl K.E.;
RT   "Epstein-Barr virus transformed cell lines superinfected with a second
RT   virus.";
RL   Patent number US5178999, 12-Jan-1993.
//
RX   PubMed=3033285; DOI=10.1128/JVI.61.5.1602-1608.1987;
RA   Dahl K.E., Martin K., Miller G.;
RT   "Differences among human immunodeficiency virus strains in their
RT   capacities to induce cytolysis or persistent infection of a
RT   lymphoblastoid cell line immortalized by Epstein-Barr virus.";
RL   J. Virol. 61:1602-1608(1987).
//